Tipifarnib in Treating Patients With Advanced Hematologic Cancer

Clinical trial NCT00005967 · COMPLETED

Trial details

NCT number: NCT00005967
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes

Start date: 2000-08-01
Primary completion: 2004-04-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.